Literature DB >> 12381354

Mycophenolic acid inhibits inosine 5'-monophosphate dehydrogenase and suppresses production of pro-inflammatory cytokines, nitric oxide, and LDH in macrophages.

Charlotte A Jonsson1, Hans Carlsten.   

Abstract

Mycophenolic acid (MPA) inhibits reversibly inosine 5(')-monophosphate dehydrogenase, an enzyme involved in the de novo synthesis of guanine nucleotides. Previously, mycophenolate mofetil (MMF), the pro-drug of MPA, was shown to exert beneficial effects on the systemic lupus erythematosus (SLE)-like disease in MRLlpr/lpr mice. In this study MPA's immunomodulating effects in vitro on the murine macrophage cell line IC-21 were investigated. The cells were exposed to MPA together with lipopolysaccharide and IFN-gamma. Cytokine, NO(2)(-), and lactate dehydrogenase levels in supernatants and cell lysates were analysed as well as the proliferation of IC-21 cells. MPA exposure reduced the total levels of all molecules investigated and suppressed the proliferation. All MPA-induced effects were reversed by the addition of guanosine to the cultures. Since macrophages play a role in lupus nephritis, our results indicate that modulation of macrophages may be involved in the ameliorating effects of MMF in SLE.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12381354     DOI: 10.1016/s0008-8749(02)00502-6

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  11 in total

1.  A one-year prospective, randomized, placebo-controlled, quadruple-blinded, phase II safety pilot trial of combination therapy with interferon beta-1a and mycophenolate mofetil in early relapsing-remitting multiple sclerosis (TIME MS).

Authors:  Gina M Remington; Katherine Treadaway; Teresa Frohman; Amber Salter; Olaf Stüve; Michael K Racke; Kathleen Hawker; Federica Agosta; Maria Pia Sormani; Massimo Filippi; Elliot M Frohman
Journal:  Ther Adv Neurol Disord       Date:  2010-01       Impact factor: 6.570

2.  A randomized, blinded, parallel-group, pilot trial of mycophenolate mofetil (CellCept) compared with interferon beta-1a (Avonex) in patients with relapsing-remitting multiple sclerosis.

Authors:  Elliot M Frohman; Gary Cutter; Gina Remington; Hongjiang Gao; Howard Rossman; Bianca Weinstock-Guttman; Jacqueline E Durfee; Amy Conger; Ellen Carl; Katherine Treadaway; Eric Lindzen; Amber Salter; Teresa C Frohman; Anjali Shah; Angela Bates; Jennifer L Cox; Michael G Dwyer; Olaf Stüve; Benjamin M Greenberg; Michael K Racke; Robert Zivadinov
Journal:  Ther Adv Neurol Disord       Date:  2010-01       Impact factor: 6.570

3.  Invasive phenotype of Candida albicans affects the host proinflammatory response to infection.

Authors:  C C Villar; H Kashleva; A P Mitchell; A Dongari-Bagtzoglou
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

4.  Responses of Bovine Innate Immunity to Mycobacterium avium subsp. paratuberculosis Infection Revealed by Changes in Gene Expression and Levels of MicroRNA.

Authors:  Michela Malvisi; Fiorentina Palazzo; Nicola Morandi; Barbara Lazzari; John L Williams; Giulio Pagnacco; Giulietta Minozzi
Journal:  PLoS One       Date:  2016-10-19       Impact factor: 3.240

5.  IMPDHII protein inhibits Toll-like receptor 2-mediated activation of NF-kappaB.

Authors:  Julie Toubiana; Anne-Lise Rossi; David Grimaldi; Nadia Belaidouni; Philippe Chafey; Guilhem Clary; Emilie Courtine; Frederic Pene; Jean-Paul Mira; Yann-Erick Claessens; Jean-Daniel Chiche
Journal:  J Biol Chem       Date:  2011-04-01       Impact factor: 5.157

6.  Mycophenolate mofetil has potent anti-inflammatory actions in a mouse model of acute lung injury.

Authors:  M G Beduschi; C L Guimarães; Z S Buss; E M Dalmarco
Journal:  Inflammation       Date:  2013-06       Impact factor: 4.092

7.  Proteomic and systems biology analysis of monocytes exposed to securinine, a GABA(A) receptor antagonist and immune adjuvant.

Authors:  Matt Shipman; Kirk Lubick; David Fouchard; Rajani Guram; Paul Grieco; Mark Jutila; Edward A Dratz
Journal:  PLoS One       Date:  2012-09-13       Impact factor: 3.240

8.  Metabolomic profiling of macrophages determines the discrete metabolomic signature and metabolomic interactome triggered by polarising immune stimuli.

Authors:  Kevin M Rattigan; Andrew W Pountain; Clement Regnault; Fiona Achcar; Isabel M Vincent; Carl S Goodyear; Michael P Barrett
Journal:  PLoS One       Date:  2018-03-14       Impact factor: 3.240

9.  Enhancement of the infectivity of SARS-CoV in BALB/c mice by IMP dehydrogenase inhibitors, including ribavirin.

Authors:  Dale L Barnard; Craig W Day; Kevin Bailey; Matthew Heiner; Robert Montgomery; Larry Lauridsen; Scott Winslow; Justin Hoopes; Joseph K-K Li; Jongdae Lee; Dennis A Carson; Howard B Cottam; Robert W Sidwell
Journal:  Antiviral Res       Date:  2006-03-24       Impact factor: 5.970

10.  A Novel Curcumin-Mycophenolic Acid Conjugate Inhibited Hyperproliferation of Tumor Necrosis Factor-Alpha-Induced Human Keratinocyte Cells.

Authors:  Yonelian Yuyun; Pahweenvaj Ratnatilaka Na Bhuket; Wiwat Supasena; Piyapan Suwattananuruk; Kemika Praengam; Opa Vajragupta; Chawanphat Muangnoi; Pornchai Rojsitthisak
Journal:  Pharmaceutics       Date:  2021-06-25       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.